Synapse - Biostatistics Service

Results (6697)

Temozolomide (TMZ) plus thalidomide (THAL) as adjuvant therapy in patients with stage III and stage IV malignant melanoma

Meeting Abstract

Hwu, W. J.; Coit, D.; Jaques, D.; Panageas, K. S.; Lamb, L. A.; Quinn, C. J.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Desmoplastic melanoma: A pathologically and clinically distinct form of cutaneous melanoma B

Meeting Abstract

Hawkins, W. G.; Busam, K. J.; BenPorat, L.; Panageas, K.; Coit, D. G.; Gyorki, D. E.; Linehan, D. C.; Brady, M. S.
Annals of Surgical Oncology (2004)

Fulltext@MSK | Save

The follicular lymphoma international prognostic index (FLIPI) is superior to WHO/REAL histological grade for identifying high-risk patients: A retrospective review of the MSKCC experience in 260 patients with follicular lymphoma

Meeting Abstract

Halaas, J. L.; Teruya-Feldstein, J.; Filippa, D. A.; Moskowitz, C.; Naresh, K. N.; Zelenetz, A. D.
Blood (2004)

Fulltext@MSK | Save

Decreasing tumor size explains some improvement in survival from localized breast cancer

Meeting Abstract

Elkin, E. B.; Schrag, D.; Hudis, C.; Begg, C. B.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Characterization of the tumor-specific activity of WT1 specific T cells generated in vitro from normal individuals by sensitization with WT1-peptide loaded autologous EBV transformed B cells

Meeting Abstract

Doubrovina, E. S.; Doubrovin, M. M.; Shieh, J.H.; Bierwiaczonek, A.; Heller, G.; Pamer, E.; O'Reilly, R. J.
Biology of Blood and Marrow Transplantation (2004)

Fulltext@MSK | Save

Phase II trial of erlotinib (OSI-774), an epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor, and bevacizumab, a recombinant humanized monoclonal antibody to vascular endothelial growth factor (VEGF), in patients (pts) with metastatic breast cancer (MBC)